Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

61. Breast Cancer: Screening

or MRI will detect additional breast cancer but will also result in a higher number of false-positive results. Data on DBT in women with dense breasts are limited, but in the short term, DBT also detects additional breast cancer. Most of the additional cancer detected by these methods are invasive tumors rather than ductal carcinoma in situ (DCIS). , A short-term increase in the number of cancer cases detected does not allow for the conclusion that adjunctive screening reduces treatment-related (...) and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Importance Breast cancer is the second-leading cause of cancer death among women in the United States. In 2015, an estimated 232,000 women were diagnosed with the disease and 40,000 women died of it. It is most frequently diagnosed among women aged 55 to 64 years, and the median age of death from breast cancer is 68 years. Benefit and Harms of Screening and Early Treatment The USPSTF found adequate

2016 U.S. Preventive Services Task Force

62. Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi Full Text available with Trip Pro

Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi 28717676 2018 11 13 2378-9506 2 1 2016 Feb Journal of global oncology J Glob Oncol Breast Cancer Screening in Low- and Middle-Income Countries: A Perspective From Malawi. 4-8 10.1200/JGO.2015.000430 Gutnik Lily A LA , Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY; , , , and , UNC-Project Malawi; , Malawi Ministry of Health; and , Kamuzu Central Hospital, Lilongwe; and , University (...) of Malawi College of Medicine, Blantyre, Malawi; , Gillings School of Global Public Health; , , and , Lineberger Comprehensive Cancer Center; and , Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC. Matanje-Mwagomba Beatrice B , Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY; , , , and , UNC-Project Malawi; , Malawi Ministry of Health; and , Kamuzu Central Hospital, Lilongwe; and , University of Malawi College

2015 Journal of global oncology

63. Digital breast tomosynthesis for breast cancer diagnosis and screening

Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Digital breast tomosynthesis for breast cancer diagnosis and screening (...) . Lansdale: HAYES, Inc.. Directory Publication. 2015 Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Humans; Mammography; Public Health; Tomography, X-Ray Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo

2015 Health Technology Assessment (HTA) Database.

64. [Invitation and fact sheet for breast cancer screening]

. Citation IQWiG. Einladungsschreiben und merkblatt zum mammographie-screening. [Invitation and fact sheet for breast cancer screening] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 288. 2015 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancers; Mass Screening Language Published German Country of organisation Germany English summary There is no English language summary available (...) [Invitation and fact sheet for breast cancer screening] Einladungsschreiben und merkblatt zum mammographie-screening [Invitation and fact sheet for breast cancer screening] Einladungsschreiben und merkblatt zum mammographie-screening [Invitation and fact sheet for breast cancer screening] IQWiG Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database

2015 Health Technology Assessment (HTA) Database.

65. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. Full Text available with Trip Pro

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. Breast cancer is a leading cause of premature mortality among US women. Early detection has been shown to be associated with reduced breast cancer morbidity and mortality.To update the American Cancer Society (ACS) 2003 breast cancer screening guideline for women at average risk for breast cancer.The ACS commissioned a systematic evidence review of the breast cancer screening literature (...) to inform the update and a supplemental analysis of mammography registry data to address questions related to the screening interval. Formulation of recommendations was based on the quality of the evidence and judgment (incorporating values and preferences) about the balance of benefits and harms.Screening mammography in women aged 40 to 69 years is associated with a reduction in breast cancer deaths across a range of study designs, and inferential evidence supports breast cancer screening for women 70

2015 JAMA

66. Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines

positive; 3-D imaging; false negative; Screen; Screened; 3 dimensional imaging; Neoplasm; Neoplasms; Tumor; Tumors; Tumour; Tumours; Breast; Breast Neoplasms; Imaging; Three-Dimensional; Mammography; Neoplasms; Predictive Value of Tests; Radiographic Image Enhancement; Sensitivity and Specificity; Breast Cancer; Cancer; Imaging Files Rapid Response Summary of Abstracts Published : September 30, 2015 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter: (...) Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines | CADTH.ca Find the information you need Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

67. Breast-Cancer Screening - Viewpoint of the IARC Working Group. (Abstract)

Breast-Cancer Screening - Viewpoint of the IARC Working Group. 26444742 2015 10 08 2018 12 02 1533-4406 373 15 2015 10 08 The New England journal of medicine N. Engl. J. Med. Breast-Cancer Screening--Viewpoint of the IARC Working Group. 1479 10.1056/NEJMc1508733 Lauby-Secretan Béatrice B Loomis Dana D Straif Kurt K eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jun 11;372(24):2353-8 26039523 N Engl J Med. 2015 Oct 8;373(15):1478 26444743 N Engl J Med (...) . 2015 Oct 8;373(15):1478-9 26444744 N Engl J Med. 2015 Oct 8;373(15):1479 26444745 Breast Neoplasms diagnosis Breast Self-Examination Early Detection of Cancer Female Humans Mammography Practice Guidelines as Topic 2015 10 8 6 0 2015 10 9 6 0 2015 10 9 6 1 ppublish 26444742 10.1056/NEJMc1508733 10.1056/NEJMc1508733#SA4

2015 NEJM

68. Breast-Cancer Screening - Viewpoint of the IARC Working Group. Full Text available with Trip Pro

Breast-Cancer Screening - Viewpoint of the IARC Working Group. 26444744 2015 10 08 2018 12 02 1533-4406 373 15 2015 10 08 The New England journal of medicine N. Engl. J. Med. Breast-Cancer Screening--Viewpoint of the IARC Working Group. 1478-9 10.1056/NEJMc1508733 Jatoi Ismail I eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jun 11;372(24):2353-8 26039523 N Engl J Med. 2015 Oct 8;373(15):1479 26444742 Breast Neoplasms diagnosis Breast Self-Examination (...) Early Detection of Cancer Female Humans Mammography Practice Guidelines as Topic 2015 10 8 6 0 2015 10 9 6 0 2015 10 9 6 1 ppublish 26444744 10.1056/NEJMc1508733 10.1056/NEJMc1508733#SA2

2015 NEJM

69. Breast-Cancer Screening - Viewpoint of the IARC Working Group. Full Text available with Trip Pro

Breast-Cancer Screening - Viewpoint of the IARC Working Group. 26444743 2015 10 08 2018 12 02 1533-4406 373 15 2015 10 08 The New England journal of medicine N. Engl. J. Med. Breast-Cancer Screening--Viewpoint of the IARC Working Group. 1478 10.1056/NEJMc1508733 Jørgensen Karsten J KJ Bewley Susan S eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jun 11;372(24):2353-8 26039523 N Engl J Med. 2015 Oct 8;373(15):1479 26444742 Breast Neoplasms diagnosis (...) Breast Self-Examination Early Detection of Cancer Female Humans Mammography Practice Guidelines as Topic 2015 10 8 6 0 2015 10 9 6 0 2015 10 9 6 1 ppublish 26444743 10.1056/NEJMc1508733 10.1056/NEJMc1508733#SA1

2015 NEJM

70. Breast-Cancer Screening - Viewpoint of the IARC Working Group. Full Text available with Trip Pro

Breast-Cancer Screening - Viewpoint of the IARC Working Group. 26444745 2015 10 08 2018 12 02 1533-4406 373 15 2015 10 08 The New England journal of medicine N. Engl. J. Med. Breast-Cancer Screening--Viewpoint of the IARC Working Group. 1479 10.1056/NEJMc1508733 Fitzgerald Stephen P SP eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jun 11;372(24):2353-8 26039523 N Engl J Med. 2015 Oct 8;373(15):1479 26444742 Breast Neoplasms diagnosis Breast Self (...) -Examination Early Detection of Cancer Female Humans Mammography Practice Guidelines as Topic 2015 10 8 6 0 2015 10 9 6 0 2015 10 9 6 1 ppublish 26444745 10.1056/NEJMc1508733 10.1056/NEJMc1508733#SA3

2015 NEJM

71. Breast cancer screening and mammography: inform women

Breast cancer screening and mammography: inform women Prescrire IN ENGLISH - Spotlight ''Breast cancer screening and mammography: inform women '', 1 July 2015 {1} {1} {1} | | > > > Breast cancer screening and mammography: inform women Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Breast cancer screening and mammography: inform women Information (...) must be shared with women to help them decide whether or not to take part in breast cancer screening. In a series of articles published over the past year, Prescrire updated its analysis of the harm-benefit balance of breast cancer screening by mammography. In France, it is estimated that, overall, for every 1000 woman aged 50, around 72 women are diagnosed with breast cancer over a period of 20 years. In the 10 years following this diagnosis, around 13 of these women die from breast cancer, and 4

2015 Prescrire

72. Breast-Cancer Screening - Viewpoint of the IARC Working Group. Full Text available with Trip Pro

Breast-Cancer Screening - Viewpoint of the IARC Working Group. 26039523 2015 06 19 2016 11 25 1533-4406 372 24 2015 Jun 11 The New England journal of medicine N. Engl. J. Med. Breast-cancer screening--viewpoint of the IARC Working Group. 2353-8 10.1056/NEJMsr1504363 Lauby-Secretan Béatrice B From the International Agency for Research on Cancer, Lyon, France (B.L.-S., C.S., D.L., L.B.-T., V.B., K.S.); and the German Cancer Research Center, Heidelberg, Germany (F.B.). Scoccianti Chiara C Loomis (...) Committees Aged Breast Neoplasms diagnosis diagnostic imaging genetics mortality Breast Self-Examination Cost-Benefit Analysis Early Detection of Cancer methods Female Humans Imaging, Three-Dimensional Mammography Middle Aged Practice Guidelines as Topic Ultrasonography Armstrong Bruce B Anttila Ahti A de Koning Harry J HJ Smith Robert A RA Thomas David B DB Weiderpass Elisabete E Anderson Benjamin O BO Badwe Rajendra A RA da Silva Ronaldo Corrêa Ferreira RC de Bock Geertruida H GH Duffy Stephen W SW

2015 NEJM

73. Tomosynthesis (3D Mammography) for Breast Cancer Screening

) (currently approved in the EU) 16 and the AMULET Innovality (Fujifilm Europe, Düsseldorf, Germany). 17 Tomosynthesis (3D Mammography) for Breast Cancer Screening 2 Patient Group Breast cancer is the most common cancer among Canadian women (excluding non-melanoma skin cancers) and the second leading cause of cancer death in this group. Canadian estimates for 2014 predicted that 24,400 women would be diagnosed with breast cancer (26% of all new cancer cases in women) and 5,000 would die from the disease (...) /en/cancer- information/cancer-type/breast/statistics/?region=bc 19. Lei J, Yang P, Zhang L, Wang Y, Yang K. Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol. 2014 Mar;24(3):595-602. 20. Lee CI, Lehman CD. Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice. J Am Coll Cardiol. 2013 Dec;10(12):913-7. 21. Canadian

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

74. Tomosynthesis (3D Mammography) for Breast Cancer Screening

in this group. Canadian estimates for 2014 predicted that 24,400 women would be diagnosed with breast cancer (26% of all new cancer cases in women) and 5,000 would die from the disease (14% of all cancer deaths in women). 18 Challenges with breast cancer are not only its incidence rate but also the lack of proven preventive strategies — early detection and treatment are currently the main approaches. 19 Screening mammography is often credited with significantly reducing the number of deaths from breast (...) , Zhang L, Wang Y, Yang K. Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol. 2014 Mar;24(3):595-602. Lee CI, Lehman CD. Digital breast tomosynthesis and the challenges of implementing an emerging breast cancer screening technology into clinical practice. J Am Coll Cardiol. 2013 Dec;10(12):913-7. Canadian Breast Cancer Foundation. Screening by mammography [Internet]. Toronto: The Foundation; 2011

2015 CADTH - Issues in Emerging Health Technologies

75. Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients

Evaluations 1. Ahern CH, Shih YC, Dong W, Parmigiani G, Shen Y. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk. Br J Cancer [Internet]. 2014 Oct 14 [cited 2015 May 6];111(8):1542-51. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200098 PubMed: PM25137022 Guidelines and Recommendations 2. Institute for Clinical Systems Improvement (ICSI). Health Care Guideline: Diagnosis of Breast Disease 14 th edition [Inetrnet (...) Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

76. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Full Text available with Trip Pro

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Mammography screening can reduce breast cancer mortality. However, most women are unaware that inconsequential disease can also be detected by screening, leading to overdiagnosis and overtreatment. We aimed to investigate whether including information about overdetection of breast cancer in a decision aid would help women aged around 50 years (...) evidence-based explanatory and quantitative information on overdetection, breast cancer mortality reduction, and false positives) or a control decision aid (including information on breast cancer mortality reduction and false positives). Participants and interviewers were masked to group assignment. The primary outcome was informed choice (defined as adequate knowledge and consistency between attitudes and screening intentions), which we assessed by telephone interview about 3 weeks after random

2015 Lancet Controlled trial quality: predicted high

77. Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis

Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Article Text Therapeutics/Prevention Observational study US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Rebecca A Hubbard Statistics from Altmetric.com Commentary on: Harding C , Pompei F , Burmistrov D , et al . Breast Cancer Screening, Incidence

2015 Evidence-Based Medicine

78. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2015 (...) Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Humans; Mammography Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000106 Date abstract

2015 Health Technology Assessment (HTA) Database.

79. Appropriate imaging for breast cancer screening in special populations

The committee reviewed and considered available guidelines including those by the American Cancer Society, National Comprehensive Cancer Network (NCCN), American College of Radiology, American Society of Breast Disease, Society for Breast Imaging, Washington State Radiological Society and European Society of Breast Imaging. The committee Chair directed HTA staff to prepare a Findings and Decision document on Appropriate Imaging for Breast Screening in Special Populations reflective of the majority vote (...) Appropriate imaging for breast cancer screening in special populations Final Appropriate Imaging for Breast Cancer: Findings & Decision Page 1 of 3 Health Technology Clinical Committee Final Findings and Decision Topic: Appropriate Imaging for Breast Cancer Screening in Special Populations Meeting Date: January 16, 2015 Final Adoption: March 20, 2015 Meeting materials and transcript are available on the HTA website: www.hca.wa.gov/hta/meetingmaterials/Forms/ExtMeetingMaterials.aspx Number

2015 Washington Health Care Authority

80. Digital Tomosynthesis for the Screening and Diagnosis of Breast Cancer

: PM25306860 2. Lei J, Yang P, Zhang L, Wang Y, Yang K. Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol. 2014 Mar;24(3):595-602. Digital Tomosynthesis for the Screening and Diagnosis of Breast Cancer 2 PubMed: PM24121712 Randomized Controlled Trials No literature identified. Non-Randomized Studies Screening 3. Bernardi D, Caumo F, Macaskill P, Ciatto S, Pellegrini M, Brunelli S, et al. Effect (...) Digital Tomosynthesis for the Screening and Diagnosis of Breast Cancer TITLE: Digital Tomosynthesis for the Screening and Diagnosis of Breast Cancer: Diagnostic Accuracy and Guidelines DATE: 23 December 2014 RESEARCH QUESTIONS 1. What is the clinical effectiveness of digital tomosynthesis compared with mammography for breast cancer screening? 2. What is the clinical effectiveness of digital tomosynthesis as an adjunct to mammography compared with mammography alone for breast cancer screening? 3

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review